Table 4.
Hepatitis B virus breakthrough infection among the studied children in different age groups
| Age group (yr) | Total | Sero-protection rate | HBV infection markers | |||
|
Anti-HBs ≥ 10 IU/L |
||||||
| n (%) | 95%CI | Anti-HBc % | HBsAg % | HBV-DNA % | ||
| < 3 | 702 | 633 (90.2) | 88.0-92.4 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| 3- | 705 | 557 (79.0) | 76.0-82.0 | 1 (0.14) | 0 (0.0) | 1 (0.14) |
| 7- | 493 | 282 (57.2) | 52.9-61.6 | 4 (0.81) | 2 (0.41) | 5 (1.00) |
| 11- | 875 | 335 (38.3) | 35.1-41.5 | 4 (0.46) | 1 (0.11) | 4 (0.46) |
| ≥ 15 | 825 | 252 (30.5) | 27.4-33.6 | 4 (0.48) | 1 (0.12) | 4 (0.48) |
| Total | 3600 | 2059 (57.2) | 55.6-58.8 | 13 (0.36) | 4 (0.11) | 14 (0.39) |
HBV: Hepatitis B virus; Anti-HBs: Hepatitis B surface antibody; Anti-HBc: Hepatitis B core antibody; HBsAg: Hepatitis B surface antigen.